Podcast

Speaking Out on Non-Small Cell Lung Cancer

Author(s):

Kristie L. Kahl

In this episode of the “CURE Talks Cancer” podcast, we spoke with Andrew Ciupek, from the Go2 Foundation for Lung Cancer, on the importance of biomarker testing and targeted therapy options for patients with non-small cell lung cancer.

While the treatment landscape for non-small cell lung cancer (NSCLC) continues to evolve, there is a heavy emphasis on discovering new targeted therapies for patients.

Because of this, it is key for patients to have their tumors tested for biomarkers to determine if they have a mutation, like EGFR, ROS1, ALK, BRAF, that could determine what treatment they should undergo. For example, Tagrisso (osimertinib) is approved by the Food and Drug Administration to treat patients with NSCLC with an EGFR mutation.

In this episode, we spoke with Andrew Ciupek, manager of clinical research at the Go2 Foundation for Lung Cancer, to learn more about biomarker testing and the various treatment options available for patients with NSCLC.

Related Content
Competing in ‘American Ninja Warrior’ and Surviving Cancer in the Same Year
July 15th 2021

Competing in ‘American Ninja Warrior’ and Surviving Cancer in the Same Year

Jamie Cesanek
In this episode of the “CURE® Talks Cancer” podcast, a woman explains how she underwent surgery and chemotherapy for cancer just months before competing in American Ninja Warrior.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
How a Survivor’s Therapeutic Blogging During Cancer Treatments Turned into Inspiration and Advocacy for Others
June 3rd 2021

How a Survivor’s Therapeutic Blogging During Cancer Treatments Turned into Inspiration and Advocacy for Others

Jamie Cesanek
In this episode of the “CURE® Talks Cancer” podcast, breast cancer survivor Tomika Bryant discusses her cancer journey, advocacy work and how blogging helped her get through treatment.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Pulling Back the Layers of Penile Cancer
September 17th 2020

Pulling Back the Layers of Penile Cancer

Ryan McDonald
In this episode of the “CURE Talks Cancer” podcast, we spoke with an expert about some of the possible causes of penile cancer, as well as why research in the field is severely lacking and why it’s so important to inform the public about what to look for in terms of signs and symptoms of this disease.
Playing with a ‘Crappy’ Set of Cards Lung Cancer Dealt
August 20th 2020

Playing with a ‘Crappy’ Set of Cards Lung Cancer Dealt

Ryan McDonald
In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Dan Tran about his journey with stage 4 lung cancer and what advice he offers other survivors and patients with cancer.